Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane Zuily

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
European Heart Journal|December 20, 2013
The future of cardiologyStephane Zuily
European Journal of Rheumatology|October 7, 2016
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosusOzan Ünlü, Stephane Zuily, Doruk Erkan
Autoimmunity Reviews|August 24, 2023
Thrombocytopenia in antiphospholipid syndrome: Is anticoagulation and/or antiaggregation always required?Stephane Zuily, Ricard Cervera, Thomas Foret, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 18, 2013
Particular catastrophic antiphospholipid syndrome, on the sole surgical site after breast reductionAntoine de Runz, Stephane Zuily, Jessica Gosset, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2024
ReplyMedha Barbhaiya, Stephane Zuily, Guilherme de Jesus, et al.
Annals of the Rheumatic Diseases|November 21, 2023
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur <i>et al</i>Doruk Erkan, Medha Barbhaiya, Stephane Zuily, et al.
Annals of the Rheumatic Diseases|November 21, 2023
Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van BeersMedha Barbhaiya, Stephane Zuily, Maria Laura Bertolaccini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2024
ReplyMedha Barbhaiya, Stephane Zuily, Alison Hendry, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Response to: Correspondence on '2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria' by Yeng et alMedha Barbhaiya, Stephane Zuily, Alison Hendry, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2023
Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugsPablo A Olivera, Juan S Lasa, Giovanni Peretto, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
European Heart Journal|December 20, 2013
The future of cardiologyStephane Zuily
European Journal of Rheumatology|October 7, 2016
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosusOzan Ünlü, Stephane Zuily, Doruk Erkan
Autoimmunity Reviews|August 24, 2023
Thrombocytopenia in antiphospholipid syndrome: Is anticoagulation and/or antiaggregation always required?Stephane Zuily, Ricard Cervera, Thomas Foret, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 18, 2013
Particular catastrophic antiphospholipid syndrome, on the sole surgical site after breast reductionAntoine de Runz, Stephane Zuily, Jessica Gosset, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2024
ReplyMedha Barbhaiya, Stephane Zuily, Guilherme de Jesus, et al.
Annals of the Rheumatic Diseases|November 21, 2023
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur <i>et al</i>Doruk Erkan, Medha Barbhaiya, Stephane Zuily, et al.
Annals of the Rheumatic Diseases|November 21, 2023
Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van BeersMedha Barbhaiya, Stephane Zuily, Maria Laura Bertolaccini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2024
ReplyMedha Barbhaiya, Stephane Zuily, Alison Hendry, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Response to: Correspondence on '2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria' by Yeng et alMedha Barbhaiya, Stephane Zuily, Alison Hendry, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2023
Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugsPablo A Olivera, Juan S Lasa, Giovanni Peretto, et al.
Pageof 4